» Authors » J Lotvall

J Lotvall

Explore the profile of J Lotvall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 120
Citations 2395
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gon Y, Maruoka S, Inoue T, Kuroda K, Yamagishi K, Kozu Y, et al.
Clin Exp Allergy . 2017 Sep; 47(12):1586-1598. PMID: 28859242
Background: MicroRNAs (miRNAs) may facilitate cell-to-cell communication via extracellular vesicles (EVs). The biological roles of miRNAs in EVs on allergic airway inflammation are unclear. Methods: Airway-secreted EVs (AEVs) were isolated...
2.
Bjerg A, Ekerljung L, Eriksson J, Naslund J, Sjolander S, Ronmark E, et al.
Clin Exp Allergy . 2016 May; 46(10):1328-36. PMID: 27159904
Background: To date, most studies of the 'allergy epidemic' have been based on self-reported data. There is still limited knowledge on time trends in allergic sensitization, especially among adults. Objective:...
3.
Ramos-Ramirez P, Malmhall C, Johansson K, Lotvall J, Bossios A
Scand J Immunol . 2016 Feb; 83(4):244-54. PMID: 26900653
Adipose tissue produces multiple mediators that modulate the immune response. Adiponectin is an adipocyte-derived cytokine that exhibits metabolic and anti-inflammatory effects. Adiponectin acts through binding to adiponectin receptor 1 and...
4.
Hochberg F, Gardiner C, Gho Y, Gupta D, Hill A, Lotvall J, et al.
J Extracell Vesicles . 2015 Jun; 3:23842. PMID: 26077417
No abstract available.
5.
Busse W, Bateman E, OByrne P, Lotvall J, Woodcock A, Medley H, et al.
Allergy . 2014 Jul; 69(11):1522-30. PMID: 25040613
Background: Inhaled glucocorticosteroids (ICS) are the mainstay of treatment in asthma. Fluticasone furoate (FF) is a novel, once-daily ICS asthma therapy. This study investigated the efficacy and safety of FF ...
6.
Zuberbier T, Lotvall J, Simoens S, Subramanian S, Church M
Allergy . 2014 Jun; 69(10):1275-9. PMID: 24965386
Background: In the European Union (EU), between 44 and 76 million individuals of the 217 million EU employees suffer from allergic disease of the airways or the skin. Up to...
7.
Eriksson J, Ekerljung L, Bossios A, Bjerg A, Wennergren G, Ronmark E, et al.
Clin Exp Allergy . 2014 Jun; 45(1):211-9. PMID: 24961377
Background: Population-based studies on aspirin-intolerant asthma (AIA) are very few, and no previous population study has investigated risk factors for the condition. Objective: To investigate the prevalence and risk factors...
8.
Newson R, Van Ree R, Forsberg B, Janson C, Lotvall J, Dahlen S, et al.
Allergy . 2014 Mar; 69(5):643-51. PMID: 24654915
Background: Geographical variation in the prevalence of sensitization to aeroallergens may reflect differences in exposure to risk factors such as having older siblings, being raised on a farm or other...
9.
Custovic A, Johnston S, Pavord I, Gaga M, Fabbri L, Bel E, et al.
Allergy . 2014 Jan; 68(12):1520-31. PMID: 24410781
Asthma exacerbations and severe asthma are linked with high morbidity, significant mortality and high treatment costs. Recurrent asthma exacerbations cause a decline in lung function and, in childhood, are linked...
10.
Bjerg A, Lotvall J
Clin Exp Allergy . 2013 Oct; 43(11):1198-9. PMID: 24152151
No abstract available.